MichelleElizabethMeliskoMD
Oncology • San Francisco, CABreast Cancer, Hematologic Oncology, Hospice & Palliative
Clinical Professor, Medicine, UCSF School of Medicine
Dr. Melisko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1825 4th St
San Francisco, CA 94143Phone+1 415-353-7070Fax+1 415-353-7692- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2000 - 2003
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1997 - 2000
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1997
Certifications & Licensure
CA State Medical License 1998 - 2024- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases Start of enrollment: 2005 Feb 01
- Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients Start of enrollment: 2007 Mar 01
- Comparing (SIS.NET) to Standard Care in Patients Who Have Completed the Acute Phase of Treatment for Early Breast Cancer Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma.Jie Jane Chen, Iowis Zhu, Akshat Patel, Florence Yuen, Gregor Krings, Yunn-Yi Chen, Rita A Mukhtar, Michelle Melisko, Lisa Singer, Catherine C Park, Nicolas D Prionas> ;Advances in Radiation Oncology. 2024 May 1
- TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic.Karen Lisa Smith, Carolyn Mead-Harvey, Gina L Mazza, Eileen H Shinn, Elizabeth S Frank, Michelle E Melisko, Cyd Eaton, Yisi Liu, Jeannine M Salamone, Teri Pollastro, P...> ;Cancer Medicine. 2024 Mar 1
- Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.Friedman, C., D'Souza, A., Bello Roufai, D., Tinker, A., de Miguel, M., Gambardella, V., Goldman, J., Loi, S., Melisko, M., Oaknin, A., Spanggaard, I., Shapiro, G., El...> ;Gynecologic Oncology. 2024 Feb 1
- Join now to see all
Press Mentions
ESMO Breast Cancer Roundtable: Episode 5November 13th, 2019
OncLive® Presents the Latest State of the Science Summit™ on Breast CancerSeptember 25th, 2018
Expert Raises QoL Concerns with Adjuvant Hormonal Therapy in ER+ Breast CancerOctober 31st, 2017- Join now to see all
Hospital Affiliations
UCSF Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
